Deciduous Therapeutics

Deciduous Therapeutics is a biotechnology company focused on developing innovative therapies for age-related diseases by targeting senescent cells. They generate revenue through partnerships, research grants, and the commercialization of their therapeutic products. Founded in 2018, the company has made significant strides in the field of cellular senescence, aiming to improve healthspan and longevity. Their proprietary platform leverages cutting-edge science to identify and eliminate harmful senescent cells, positioning them at the forefront of regenerative medicine.

Recent Posts by Deciduous Therapeutics

1-1 of 1